TATUM bioscience is a therapeutics company based in Sherbrooke, QC, concentrating on developing a new type of immunotherapy for cancer treatment. Their approach involves a modular synthetic biology platform to develop nanofilaments that are designed to help stimulate the immune system to target tumors. This method aims to enhance the immune system's ability to recognize and attack cancer cells, potentially improving treatment outcomes.